Dynatronics Corporation
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Dynatronics Corporation - overview
Established
1979
Location
Salt Lake City, UT, US
Primary Industry
Medical Devices & Equipment
About
Dynatronics Corporation is focused on developing and manufacturing advanced therapeutic equipment, offering innovative solutions in electrotherapy and light therapy for healthcare providers. Founded in 1979 in Salt Lake City, US, Dynatronics Corporation specializes in therapeutic equipment development. The company's latest funding round was a PIPE in December 2016, raising USD 0. 98 mn from Prettybrook Partners.
Dynatronics has successfully executed 2 deals, maintaining a consistent focus on therapeutic innovation. Dynatronics Corporation specializes in the development and manufacturing of advanced therapeutic equipment, with a primary focus on electrotherapy and light therapy modalities. Their flagship product, the Solaris Plus, integrates electrotherapy, TriWave Light, and ultrasound capabilities, offering comprehensive treatment solutions for clinics, hospitals, and athletic training facilities. The devices address clinical needs such as pain reduction, functional improvement, and soft tissue mobilization, enhancing traditional treatment protocols.
The company serves a range of healthcare providers, including physical therapists, athletic trainers, and rehabilitation centers, particularly in North America and select international markets. In the most recent year, Dynatronics reported revenue of USD 32. 53 mn, with an EBITDA of USD -0. 82 mn.
The company generates revenue through direct sales of therapeutic products to healthcare facilities, engaging in business-to-business transactions to support patient care; pricing strategies reflect a competitive approach within the industry and a commitment to enhancing therapeutic outcomes. Dynatronics plans to utilize the funds raised in the recent PIPE round to support upcoming product launches and market expansions. The company is designing new therapeutic solutions aimed at enhancing its existing product line, with plans for release in 2024. Furthermore, Dynatronics is targeting growth in both domestic and select international markets, building on its established presence since 1979, as it continues to expand its reach in providing advanced therapeutic equipment.
Current Investors
Prettybrook Partners
Primary Industry
Medical Devices & Equipment
Sub Industries
Therapeutic Devices
Website
www.dynatronics.com
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
Dynatronics Corporation - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Hausmann Industries, Inc. | - | ||||||||
| PIPE | Completed | Dynatronics Corporation | - | ||||||||
| PIPE | Completed | Dynatronics Corporation | - |
Displaying 1 - 3 of 3

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.